Aurora Spine's Patent Related to its Polyaxial ZIP® ISP Issued by the United States Patent Office

CARLSBAD, CALIFORNIA--(Marketwired - April 12, 2017) - Aurora Spine Corporation (TSX VENTURE:ASG) ("Aurora" or "Aurora Spine") announced today the issuance of its United States Patent No.: 9,603,637 entitled "POLYAXIAL INTERSPINOUS FUSION IMPLANT AND BONE GROWTH STIMULATION SYSTEM." In addition to Aurora's implant family of ZIP® ISPs, including its ZIP Ultra®, ZIP 51™, ZIP LP™, Dyna-ZIP™ and ZIP-Flex, this patent application covers the company's first polyaxial implant design.

Read More
Christian Flores
Aurora Spine Attending NASS 2016 in Boston, Massachusetts

Carlsbad, California, October 25, 2016 /Marketwired/ - Aurora Spine Corporation (TSXV: ASG) announced today that it will be participating at the 2016 North American Spine Society ("NASS") Annual Meeting, October 26 - 28, 2016 at the Boston Convention and Exhibition Center Boston, Massachusettsat Booth 1302. The North American Spine Society is a global multidisciplinary medical society that utilizes education, research and advocacy to foster the highest quality, ethical, value and evidence based spine care.

Read More
Christian Flores
Aurora Spine's New Mobile App!

Carlsbad, California, October 21st, 2016 - Aurora Spine is proud to announce the launch of the new Aurora Spine Mobile App! Aurora Spine's Mobile App is denied to bring information regarding all the new and exciting products being offered straight to your mobile device. The app is currently available for Apple, Android, and iPad devices.

Read More
AURORA SPINE’S PATENT RELATED TO ITS ZIP® ISP ALLOWED BY THE UNITED STATES PATENT OFFICE

Carlsbad, California, April 14, 2016 /Marketwired/ - Aurora Spine Corporation (TSXV: ASG) announced today the allowance by the United States Patent and Trademark Office of United States Patent Application Serial No. 13/865,155 entitled “Dynamic and Non-Dynamic Interspinous Fusion Implant and Bone Growth Stimulation System”.  This patent covers Aurora’s family of ZIP® ISPs, including its ZIP Ultra®, ZIP 51™, ZIP LP™ and Dyna-ZIP™ among others.

Read More
Christian Flores
FIRST SURGICAL IMPLANT OF ZIP ULTRA™ MIS INTERSPINOUS DEVICE PERFORMED IN SWITZERLAND

Aurora Spine Corporation (TSX VENTURE:ASG) announced today(02/09/2015) the first surgical implant of the company's ZIP ULTRA™ minimally invasive interspinous device in Switzerland. This surgery is part of Aurora Spine's continuing efforts to expand the use of our ZIP MIS Fusion System in Europe. The surgery was performed at the Clinique Générale-Beaulieu in Geneva by Prof. Aymen Ramadan.

Read More
Christian Flores
AURORA SPINE RECEIVES HEALTH CANADA MEDICAL DEVICE LICENSE FOR ZIP™ MIS INTERSPINOUS FUSION SYSTEM

Aurora Spine Corporation (TSXV:ASG) announced today(12/09/2014) that it has received the Health Canada Medical Device License for its ZIP™ Interspinous Fusion System. Aurora Spine's ZIP MIS Interspinous fixation implant for spinal fusion, consists of a ONE-STEP™ locking mechanism, articulating spikes and various sizes to accommodate variations in patient anatomy which eliminates the use of a set screw.

Read More
Christian Flores
Aurora Spine to Present at Brean Capital Life Sciences Summit Conference

Aurora Spine Corporation (TSX VENTURE:ASG) announced today(11/22/2014) that it will be presenting at the Brean Capital Life Sciences Summit Conference in New York, NY on November 24, 2014. Brean Capital's Corporate Access product offering includes a number of industry-specific and regional "best idea" investment conferences to facilitate the interaction of company management and institutional investors throughout the year.

Read More
Christian Flores
Aurora Spine Announces Expansion of U.S. Hospital Network Through Agreement With MedAssets

Aurora Spine Corporation (TSX VENTURE:ASG) announced it has entered into a national contract with MedAssets. MedAssets is one of the nation's largest third-party providers of supply chain management and outsourced procurement capabilities. MedAssets manages, on behalf of its clients, more than $50 billion in supply expense per year through the MedAssets National Procurement Center.

Read More
Christian Flores